Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

E Boerwinkle

Showing results (151-160 of 174) with videos related to

Pageof 18
Sort By:
American Journal of Human Genetics|September 14, 2000
Apolipoprotein E variation at the sequence haplotype level: implications for the origin and maintenance of a major human polymorphismS M Fullerton, A G Clark, K M Weiss, et al.
The Pharmacogenomics Journal|February 13, 2013
Genome-wide association analyses suggest NELL1 influences adverse metabolic response to HCTZ in African AmericansJ L Del-Aguila, A L Beitelshees, R M Cooper-Dehoff, et al.
Journal of Hypertension|February 24, 2001
Linkage of hypertension to chromosome 2q14-q23 in Chinese familiesD L Zhu, H Y Wang, M M Xiong, et al.
International Journal of Obesity (2005)|October 12, 2011
The association of variants in the FTO gene with longitudinal body mass index profiles in non-Hispanic white children and adolescentsD M Hallman, V C Friedel, M A H Eissa, et al.
Circulation|June 17, 1997
Genetic variant showing a positive interaction with beta-blocking agents with a beneficial influence on lipoprotein lipase activity, HDL cholesterol, and triglyceride levels in coronary artery disease patients. The Ser447-stop substitution in the lipoprotein lipase gene. REGRESS Study GroupB E Groenemeijer, M D Hallman, P W Reymer, et al.
Clinical Pharmacology and Therapeutics|July 3, 2009
Hydrochlorothiazide and atenolol combination antihypertensive therapy: effects of drug initiation orderJ A Johnson, Y Gong, K R Bailey, et al.
The Pharmacogenomics Journal|February 22, 2012
Association of chromosome 12 locus with antihypertensive response to hydrochlorothiazide may involve differential YEATS4 expressionJ D Duarte, S T Turner, B Tran, et al.
Clinical Genetics|April 29, 1998
The Asn9 variant of lipoprotein lipase is associated with the -93G promoter mutation and an increased risk of coronary artery disease. The Regress Study GroupJ J Kastelein, B E Groenemeyer, D M Hallman, et al.
Journal of Internal Medicine|March 12, 2014
Hydrochlorothiazide-induced hyperuricaemia in the pharmacogenomic evaluation of antihypertensive responses studyA G Vandell, C W McDonough, Y Gong, et al.
Journal of Thrombosis and Haemostasis : JTH|May 19, 2006
Association between patterns of nucleotide variation across the three fibrinogen genes and plasma fibrinogen levels: the Coronary Artery Risk Development in Young Adults (CARDIA) studyA P Reiner, C L Carty, C S Carlson, et al.
Pageof 18

Showing results (151-160 of 174) with videos related to

Sort By:
Pageof 18
American Journal of Human Genetics|September 14, 2000
Apolipoprotein E variation at the sequence haplotype level: implications for the origin and maintenance of a major human polymorphismS M Fullerton, A G Clark, K M Weiss, et al.
The Pharmacogenomics Journal|February 13, 2013
Genome-wide association analyses suggest NELL1 influences adverse metabolic response to HCTZ in African AmericansJ L Del-Aguila, A L Beitelshees, R M Cooper-Dehoff, et al.
Journal of Hypertension|February 24, 2001
Linkage of hypertension to chromosome 2q14-q23 in Chinese familiesD L Zhu, H Y Wang, M M Xiong, et al.
International Journal of Obesity (2005)|October 12, 2011
The association of variants in the FTO gene with longitudinal body mass index profiles in non-Hispanic white children and adolescentsD M Hallman, V C Friedel, M A H Eissa, et al.
Circulation|June 17, 1997
Genetic variant showing a positive interaction with beta-blocking agents with a beneficial influence on lipoprotein lipase activity, HDL cholesterol, and triglyceride levels in coronary artery disease patients. The Ser447-stop substitution in the lipoprotein lipase gene. REGRESS Study GroupB E Groenemeijer, M D Hallman, P W Reymer, et al.
Clinical Pharmacology and Therapeutics|July 3, 2009
Hydrochlorothiazide and atenolol combination antihypertensive therapy: effects of drug initiation orderJ A Johnson, Y Gong, K R Bailey, et al.
The Pharmacogenomics Journal|February 22, 2012
Association of chromosome 12 locus with antihypertensive response to hydrochlorothiazide may involve differential YEATS4 expressionJ D Duarte, S T Turner, B Tran, et al.
Clinical Genetics|April 29, 1998
The Asn9 variant of lipoprotein lipase is associated with the -93G promoter mutation and an increased risk of coronary artery disease. The Regress Study GroupJ J Kastelein, B E Groenemeyer, D M Hallman, et al.
Journal of Internal Medicine|March 12, 2014
Hydrochlorothiazide-induced hyperuricaemia in the pharmacogenomic evaluation of antihypertensive responses studyA G Vandell, C W McDonough, Y Gong, et al.
Journal of Thrombosis and Haemostasis : JTH|May 19, 2006
Association between patterns of nucleotide variation across the three fibrinogen genes and plasma fibrinogen levels: the Coronary Artery Risk Development in Young Adults (CARDIA) studyA P Reiner, C L Carty, C S Carlson, et al.
Pageof 18